Thaibah, H.A.; Banji, O.J.F.; Banji, D.; Almansour, H.A.; Alshammari, T.M.
Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports. Pharmaceuticals 2025, 18, 957.
https://doi.org/10.3390/ph18070957
AMA Style
Thaibah HA, Banji OJF, Banji D, Almansour HA, Alshammari TM.
Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports. Pharmaceuticals. 2025; 18(7):957.
https://doi.org/10.3390/ph18070957
Chicago/Turabian Style
Thaibah, Hilal A., Otilia J. F. Banji, David Banji, Hadi A. Almansour, and Thamir M. Alshammari.
2025. "Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports" Pharmaceuticals 18, no. 7: 957.
https://doi.org/10.3390/ph18070957
APA Style
Thaibah, H. A., Banji, O. J. F., Banji, D., Almansour, H. A., & Alshammari, T. M.
(2025). Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports. Pharmaceuticals, 18(7), 957.
https://doi.org/10.3390/ph18070957
